8 independently checked trend briefs about this subject, newest first.
headlinez.news detected 8 source-qualified news clusters connected to Vaccine between June 23, 2026 and July 27, 2026. They span 1 newsroom category and average 8.4 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
U.S. measles cases have reached a 35-year high, prompting urgent vaccine pushes as outbreaks surpass previous annual totals.
The first human participant has received an experimental vaccine targeting the Bundibugyo ebolavirus strain as clinical trials launch in the DRC.
Recent advancements in mRNA technology are generating renewed optimism for the development of a viable HIV vaccine.
India has granted approval to Qdenga, Takeda's vaccine, marking the nation's first regulatory clearance for a dengue immunization.
A new experimental KRAS-targeted vaccine shows promise in early trials for preventing pancreatic cancer in high-risk individuals.
The University of Oxford has launched the world's first human clinical trial for a vaccine targeting the Bundibugyo strain of the Ebola virus.
A personalized cancer vaccine targeting glioblastoma mutations enters clinical trials, showing potential for extended patient survival.
A COVID-19 vaccine study previously blocked by the acting CDC director has been published in an outside medical journal.